Environmental risk factors for inflammatory bowel disease.

Oral contraceptives, reproductive factors and risk of inflammatory bowel disease. Gut (2012) 2.65

Is moderate red wine consumption safe in inactive inflammatory bowel disease? Digestion (2011) 1.49

A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clin Epidemiol (2013) 1.40

The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol (2015) 1.34

Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's disease. PLoS One (2012) 1.28

Environment and the inflammatory bowel diseases. Can J Gastroenterol (2013) 1.07

Inflammatory bowel disease: an expanding global health problem. Clin Med Insights Gastroenterol (2013) 1.07

Impact of environmental and dietary factors on the course of inflammatory bowel disease. World J Gastroenterol (2012) 1.03

Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease. Exp Biol Med (Maywood) (2014) 1.03

The emerging role of miRNAs in inflammatory bowel disease: a review. Therap Adv Gastroenterol (2015) 1.03

The incidence of inflammatory bowel disease in Northern China: a prospective population-based study. PLoS One (2014) 0.99

The C5a receptor antagonist PMX205 ameliorates experimentally induced colitis associated with increased IL-4 and IL-10. Br J Pharmacol (2013) 0.94

Linking vitamin d deficiency to inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.92

Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease. Mediators Inflamm (2014) 0.92

Effect of the C3435T polymorphism of the multidrug resistance 1 gene on the severity of inflammatory bowel disease in Iranian Azeri Turks. Saudi J Gastroenterol (2013) 0.89

Heritability in inflammatory bowel disease: from the first twin study to genome-wide association studies. Inflamm Bowel Dis (2015) 0.87

Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease. Dig Dis Sci (2015) 0.85

Chemistry meets biology in colitis-associated carcinogenesis. Free Radic Res (2013) 0.83

Dietary red meat aggravates dextran sulfate sodium-induced colitis in mice whereas resistant starch attenuates inflammation. Dig Dis Sci (2013) 0.83

Mitochondrial dysfunction in inflammatory bowel disease. Front Cell Dev Biol (2015) 0.83

Activation of the NF κ B Pathway Enhances AhR Expression in Intestinal Caco-2 Cells. ISRN Toxicol (2013) 0.81

Differential effect of vitamin D on NOD2- and TLR-induced cytokines in Crohn's disease. Mucosal Immunol (2014) 0.81

Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults. World J Gastrointest Pharmacol Ther (2016) 0.79

Protective effect of the methanolic extract of malva parviflora l. leaves on acetic acid-induced ulcerative colitis in rats. Saudi J Gastroenterol (2016) 0.79

Dietary ganglioside reduces proinflammatory signaling in the intestine. J Nutr Metab (2012) 0.79

Paediatric inflammatory bowel disease: a mechanistic approach to investigate exclusive enteral nutrition treatment. Scientifica (Cairo) (2014) 0.79

Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: A brief review. Saudi Pharm J (2014) 0.78

The Faroese IBD Study: Incidence of Inflammatory Bowel Diseases Across 54 Years of Population-based Data. J Crohns Colitis (2016) 0.78

The Association of Smoking and Surgery in Inflammatory Bowel Disease is Modified by Age at Diagnosis. Clin Transl Gastroenterol (2016) 0.78

Crohn Disease Risk Prediction-Best Practices and Pitfalls with Exome Data. Hum Mutat (2017) 0.77

Crohn's Disease Localization Displays Different Predisposing Genetic Variants. PLoS One (2017) 0.77

Autophagy deficiency in myeloid cells increases susceptibility to obesity-induced diabetes and experimental colitis. Autophagy (2016) 0.77

Association between STAT3 gene polymorphisms and Crohn's disease susceptibility: a case-control study in a Chinese Han population. Diagn Pathol (2014) 0.77

Clinical diagnostic clues in Crohn's disease: a 41-year experience. ISRN Gastroenterol (2012) 0.76

An indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitis. Arch Med Sci (2016) 0.76

Topological distortion and reorganized modular structure of gut microbial co-occurrence networks in inflammatory bowel disease. Sci Rep (2016) 0.76

Interleukin-17 SNPs and serum levels increase ulcerative colitis risk: a meta-analysis. World J Gastroenterol (2014) 0.75

Family history and disease outcomes in patients with Crohn's disease: A comparison between China and the United States. World J Gastrointest Pharmacol Ther (2016) 0.75

Visceral Adiposity, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease. Inflamm Bowel Dis (2016) 0.75

Bowel disorders and its spatial trend in Manitoba, Canada. BMC Public Health (2014) 0.75

Role of Salmonella enterica exposure in Chilean Crohn's disease patients. World J Gastroenterol (2013) 0.75

Smoking Is Associated with an Increased Risk for Surgery in Diverticulitis: A Case Control Study. PLoS One (2016) 0.75

The ecological community of commensal, symbiotic, and pathogenic gastrointestinal microorganisms - an appraisal. Clin Exp Gastroenterol (2017) 0.75

MDR1C3435T polymorphism and inflammatory bowel disease. Saudi J Gastroenterol (2015) 0.75

Genetic association between CARD9 variants and inflammatory bowel disease was not replicated in a Chinese Han population. Int J Clin Exp Pathol (2015) 0.75

Oral Contraceptive Use and Risk of Ulcerative Colitis Progression: A Nationwide Study. Am J Gastroenterol (2016) 0.75

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology (2004) 14.78

Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet (2004) 6.84

Is measles vaccination a risk factor for inflammatory bowel disease? Lancet (1995) 6.75

High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology (2004) 5.94

Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. Gastroenterology (2007) 5.40

Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology (2005) 5.26

Trichuris suis therapy in Crohn's disease. Gut (2005) 4.05

A case-control study of measles vaccination and inflammatory bowel disease. The East Dorset Gastroenterology Group. Lancet (1997) 3.77

The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol (2006) 3.76

Exposure to measles in utero and Crohn's disease: Danish register study. BMJ (1998) 3.48

Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect Dis (2003) 3.42

Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol (1999) 3.34

Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease. J Clin Microbiol (2003) 3.09

Inflammatory bowel disease and domestic hygiene in infancy. Lancet (1994) 3.08

Protagonist. Mycobacterium avium subspecies paratuberculosis is a cause of Crohn's disease. Gut (2001) 3.01

A population-based case control study of potential risk factors for IBD. Am J Gastroenterol (2006) 2.91

Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect Dis (2007) 2.85

New genes in inflammatory bowel disease: lessons for complex diseases? Lancet (2006) 2.72

Appendectomy is followed by increased risk of Crohn's disease. Gastroenterology (2003) 2.62

Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology (2009) 2.57

Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scand J Gastroenterol (1987) 2.54

A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci (1989) 2.53

Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J Biol Chem (2004) 2.36

Appendectomy and subsequent risk of inflammatory bowel diseases. Surgery (2001) 2.35

Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. Am J Clin Nutr (2004) 2.32

Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology (2002) 2.27

Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol (2009) 2.23

Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut (2005) 2.20

Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study. Am J Gastroenterol (2000) 2.14

Perinatal measles infection and subsequent Crohn's disease. Lancet (1994) 2.11

Mycobacteria and inflammatory bowel disease. Results of culture. Gastroenterology (1987) 2.07

The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol (2008) 2.06

Appendectomy and the risk of developing ulcerative colitis or Crohn's disease: results of a large case-control study. South Limburg Inflammatory Bowel Disease Study Group. Gastroenterology (1997) 2.04

Appendicectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: a case control study. Gut (1998) 2.02

Crohn's disease after in-utero measles virus exposure. Lancet (1996) 1.98

Johne's disease, inflammatory bowel disease, and Mycobacterium paratuberculosis. Annu Rev Microbiol (2004) 1.98

Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut (2002) 1.96

Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm Bowel Dis (2010) 1.86

Bottle feeding, early gastroenteritis, and inflammatory bowel disease. Br Med J (1979) 1.83

Contact with farm animals in early life and juvenile inflammatory bowel disease: a case-control study. Pediatrics (2007) 1.82

Modern life' in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol (1998) 1.80

Antagonist. Mycobacterium avium subspecies paratuberculosis is a cause of Crohn's disease. Gut (2001) 1.77

Evidence of persistent measles virus infection in Crohn's disease. J Med Virol (1993) 1.76

Reversible alterations in immunoregulatory T cells in smoking. Analysis by monoclonal antibodies and flow cytometry. Chest (1982) 1.76

The risk of developing Crohn's disease after an appendectomy: a meta-analysis. Am J Gastroenterol (2008) 1.74

Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm Bowel Dis (2006) 1.73

Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology (2006) 1.71

Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. Gastroenterology (2002) 1.68

Appendectomy and the development of ulcerative colitis: results of a metaanalysis of published case-control studies. Am J Gastroenterol (2000) 1.68

Absence of measles virus in Crohn's disease. Lancet (1995) 1.67

Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis (2004) 1.65

Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut (2005) 1.65

Inflammatory bowel disease and tobacco smoke--a case-control study. Gut (1990) 1.63

Appendectomy is more frequent but not a risk factor in Crohn's disease while being protective in ulcerative colitis: a comparison of surgical procedures in inflammatory bowel disease. Am J Gastroenterol (2001) 1.63

Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev (2004) 1.61

Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice. J Exp Med (1996) 1.59

Antibiotic use and the development of Crohn's disease. Gut (2004) 1.56

The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol (2005) 1.55

Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut (2008) 1.54

Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis (2005) 1.52

Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease. Gut (1990) 1.51

Lack of support for a common etiology in Johne's disease of animals and Crohn's disease in humans. Inflamm Bowel Dis (1999) 1.49

Absence of measles viral genomic sequence in intestinal tissues from Crohn's disease by nested polymerase chain reaction. Gut (1996) 1.41

Review article: the pharmacological implications of leucocyte-endothelial cell interactions in Crohn's disease. Aliment Pharmacol Ther (1991) 1.40

Risk factors for inflammatory bowel disease in the general population. Aliment Pharmacol Ther (2005) 1.38

Estrogens and autoimmune diseases. Ann N Y Acad Sci (2006) 1.37

Lack of induction of suppressor T cells by intestinal epithelial cells from patients with inflammatory bowel disease. J Clin Invest (1990) 1.35

Nonspecific inflammatory bowel disease and smoking. Am J Epidemiol (1987) 1.34

Population-based case control study of seroprevalence of Mycobacterium paratuberculosis in patients with Crohn's disease and ulcerative colitis. J Clin Microbiol (2004) 1.34

Role of appendicitis and appendectomy in the pathogenesis of ulcerative colitis: a critical review. Inflamm Bowel Dis (2002) 1.33

A population-based ecologic study of inflammatory bowel disease: searching for etiologic clues. Am J Epidemiol (2006) 1.33

Role of infant feeding practices in development of Crohn's disease in childhood. BMJ (1989) 1.32

The physiology of lactoferrin. Biochem Cell Biol (2002) 1.31

PCR detection of Mycobacterium paratuberculosis in Crohn's disease granulomas isolated by laser capture microdissection. Gut (2002) 1.31

Childhood infections and the risk of inflammatory bowel disease. Dig Dis Sci (1994) 1.29

Pre-illness dietary factors in inflammatory bowel disease. Gut (1997) 1.29

Smoking and colonic mucus in ulcerative colitis. Br Med J (Clin Res Ed) (1986) 1.28

T cells express alpha7-nicotinic acetylcholine receptor subunits that require a functional TCR and leukocyte-specific protein tyrosine kinase for nicotine-induced Ca2+ response. J Immunol (2007) 1.27

Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol (2007) 1.26

Early weaning in the aetiology of ulcerative colitis. A study of feeding in infancy in cases and controls. Br Med J (1961) 1.23

Mapping of inflammatory bowel disease in northern France: spatial variations and relation to affluence. Inflamm Bowel Dis (2010) 1.23

Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. World J Gastroenterol (2008) 1.21

Perinatal risk factors for inflammatory bowel disease: a case-control study. Am J Epidemiol (1990) 1.20

Appendicectomy, tonsillectomy, and inflammatory bowel disease: a case-control record linkage study. J Epidemiol Community Health (2002) 1.19

Study of animal-borne infections in the mucosas of patients with inflammatory bowel disease and population-based controls. J Clin Microbiol (2003) 1.16

Diet as a risk factor for the development of ulcerative colitis. Am J Gastroenterol (2000) 1.16

Crohn's disease in mainland China: a systematic analysis of 50 years of research. Chin J Dig Dis (2005) 1.15

A case-control study of childhood environmental risk factors for the development of inflammatory bowel disease. Eur J Gastroenterol Hepatol (2002) 1.15

The evolving epidemiology of inflammatory bowel disease. Curr Opin Gastroenterol (2009) 1.13

Stressful life events as a risk factor for inflammatory bowel disease onset: A population-based case-control study. Am J Gastroenterol (2006) 1.13

Past and current theories of etiology of IBD: toothpaste, worms, and refrigerators. J Clin Gastroenterol (2005) 1.12

Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project. Arch Pediatr Adolesc Med (2001) 1.07

Candida albicans colonization and ASCA in familial Crohn's disease. Am J Gastroenterol (2009) 1.07

Investigating the hygiene hypothesis as a risk factor in pediatric onset Crohn's disease: a case-control study. Am J Gastroenterol (2006) 1.05

Early-life exposures associated with antibiotic use and risk of subsequent Crohn's disease. Scand J Gastroenterol (2008) 1.05

Crohn's disease: pathogenesis and persistent measles virus infection. Gastroenterology (1995) 1.05

Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut (1995) 1.04

Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: current perspectives. Pharmacol Res (2002) 1.02

Measles virus RNA is not detected in inflammatory bowel disease using hybrid capture and reverse transcription followed by the polymerase chain reaction. J Med Virol (1998) 0.99

Immune potentiation of ultrafine dietary particles in normal subjects and patients with inflammatory bowel disease. J Autoimmun (2000) 0.97

Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology (2011) 12.09

Weekend versus weekday admission and mortality from gastrointestinal hemorrhage caused by peptic ulcer disease. Clin Gastroenterol Hepatol (2008) 2.89

Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis (2011) 2.62

A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol (2008) 2.57

Bowel obstruction following appendectomy: what is the true incidence? Ann Surg (2009) 2.50

The increasing weight of Crohn's disease subjects in clinical trials: a hypothesis-generatings time-trend analysis. Inflamm Bowel Dis (2013) 2.05

Opposing effects of smoking in ulcerative colitis and Crohn's disease may be explained by differential effects on dendritic cells. Inflamm Bowel Dis (2014) 2.03

A population-based study of pyogenic liver abscesses in the United States: incidence, mortality, and temporal trends. Am J Gastroenterol (2009) 1.84

Depression in epilepsy: a systematic review and meta-analysis. Neurology (2012) 1.80

Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology (2013) 1.79

Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure. Eur Respir J (2013) 1.54

Predicting in-hospital mortality in patients undergoing complex gastrointestinal surgery: determining the optimal risk adjustment method. Arch Surg (2011) 1.54

Laparoscopic versus open resection for colorectal cancer: a metaanalysis of oncologic outcomes. J Am Coll Surg (2007) 1.36

Challenges associated with identifying the environmental determinants of the inflammatory bowel diseases. Inflamm Bowel Dis (2010) 1.31

Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients. Inflamm Bowel Dis (2013) 1.25

Postoperative complications and mortality following colectomy for ulcerative colitis. Clin Gastroenterol Hepatol (2011) 1.24

Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals. J Proteome Res (2012) 1.21

The role of TNFalpha in ulcerative colitis. J Clin Pharmacol (2007) 1.20

Defining quality indicators for best-practice management of inflammatory bowel disease in Canada. Can J Gastroenterol Hepatol (2014) 1.19

Predicting in-hospital mortality in patients with cirrhosis: results differ across risk adjustment methods. Hepatology (2009) 1.17

Microscopic colitis-defining incidence rates and risk factors: a population-based study. Clin Gastroenterol Hepatol (2008) 1.13

Environment and the inflammatory bowel diseases. Can J Gastroenterol (2013) 1.07

Isotretinoin and intestinal inflammation: what gastroenterologists need to know. Gut (2009) 1.07

Incidence and prevalence of eosinophilic esophagitis in children. J Pediatr Gastroenterol Nutr (2013) 1.07

Environmental particulate matter induces murine intestinal inflammatory responses and alters the gut microbiome. PLoS One (2013) 1.07

Living with inflammatory bowel disease: A Crohn's and Colitis Canada survey. Can J Gastroenterol Hepatol (2015) 1.03

The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis. BMC Gastroenterol (2012) 0.98

Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis. Hepatology (2011) 0.97

Validity of administrative data for the diagnosis of primary sclerosing cholangitis: a population-based study. Liver Int (2011) 0.96

Postoperative complications following colectomy for ulcerative colitis: a validation study. BMC Gastroenterol (2012) 0.96

Epidemiology of gastrointestinal stromal tumors in a defined Canadian Health Region: a population-based study. Int J Surg Pathol (2008) 0.96

The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all. Clin Gastroenterol Hepatol (2010) 0.95

Postoperative complications following colectomy for ulcerative colitis in children. J Pediatr Gastroenterol Nutr (2012) 0.95

The feasibility and reliability of transient elastography using Fibroscan®: a practice audit of 2335 examinations. Can J Gastroenterol Hepatol (2014) 0.94

Immunogenicity and safety of influenza vaccination in children with inflammatory bowel disease. Inflamm Bowel Dis (2011) 0.93

Emergency department visits for migraine and headache: a multi-city study. Int J Occup Med Environ Health (2009) 0.93

Hospital performance reports based on severity adjusted mortality rates in patients with cirrhosis depend on the method of risk adjustment . Ann Hepatol (2012) 0.92

Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease. Inflamm Bowel Dis (2014) 0.90

Amoebic liver abscess in USA: a population-based study of incidence, temporal trends and mortality. Liver Int (2011) 0.90

Ambient sulphur dioxide exposure and emergency department visits for migraine in Vancouver, Canada. Int J Occup Med Environ Health (2009) 0.89

Budesonide for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev (2014) 0.87

Postoperative complications and emergent readmission in children and adults with inflammatory bowel disease who undergo intestinal resection: a population-based study. Inflamm Bowel Dis (2014) 0.84

Inflammatory bowel disease cause-specific mortality: a primer for clinicians. Inflamm Bowel Dis (2014) 0.84

Clostridium difficile infection worsens the prognosis of ulcerative colitis. Can J Gastroenterol Hepatol (2014) 0.84

Budesonide for induction of remission in Crohn's disease. Cochrane Database Syst Rev (2015) 0.84

Challenges in designing a national surveillance program for inflammatory bowel disease in the United States. Inflamm Bowel Dis (2014) 0.83

Hospitalizations for inflammatory bowel disease: profile of the uninsured in the United States. Inflamm Bowel Dis (2009) 0.83

Relationship between hospital volume and outcomes of esophageal variceal bleeding in the United States. Clin Gastroenterol Hepatol (2008) 0.82

Characteristics of patients with cirrhosis who are discharged from the hospital against medical advice. Clin Gastroenterol Hepatol (2009) 0.82

Administrative database studies in IBD: a cautionary tale. Am J Gastroenterol (2010) 0.81

Drug-induced inflammatory bowel disease and IBD-like conditions. Inflamm Bowel Dis (2013) 0.81

Managing the risks of IBD therapy. Curr Gastroenterol Rep (2009) 0.79

Serrated adenoma prevalence in inflammatory bowel disease surveillance colonoscopy, and characteristics revealed by chromoendoscopy and virtual chromoendoscopy. Can J Gastroenterol Hepatol (2014) 0.79

Exposure to ingested airborne pollutant particulate matter increases mucosal exposure to bacteria and induces early onset of inflammation in neonatal IL-10-deficient mice. Inflamm Bowel Dis (2014) 0.79

Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease. Inflamm Bowel Dis (2016) 0.79

Ambient ozone and emergency department visits for cellulitis. Int J Environ Res Public Health (2010) 0.78

Morbidity and mortality following coronary artery bypass graft surgery in patients with cirrhosis: a population-based study. Liver Int (2009) 0.78

Nationwide temporal trends in incidence of hospitalization and surgical intestinal resection in pediatric inflammatory bowel diseases in the United States from 1997 to 2009. Inflamm Bowel Dis (2013) 0.78

Novel CD8+ T-Cell Subsets Demonstrating Plasticity in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis (2016) 0.78

Immunogenicity of Influenza Vaccine for Patients with Inflammatory Bowel Disease on Maintenance Infliximab Therapy: A Randomized Trial. Inflamm Bowel Dis (2016) 0.77

Anti-tumor necrosis factor therapy and influenza: keeping it in perspective. Therap Adv Gastroenterol (2010) 0.77

Helminth Regulation of Immunity: A Three-pronged Approach to Treat Colitis. Inflamm Bowel Dis (2016) 0.77

Ulcerative colitis-associated hospitalization costs: A population-based study. Can J Gastroenterol Hepatol (2015) 0.75

Hospital volume and other risk factors for in-hospital mortality among diverticulitis patients: A nationwide analysis. Can J Gastroenterol Hepatol (2015) 0.75

Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame. Expert Rev Vaccines (2015) 0.75

Predictors of mortality among patients undergoing colectomy for ischemic colitis: A population-based United States study. Can J Gastroenterol Hepatol (2014) 0.75

Risk factors for mortality in patients with alcoholic hepatitis and assessment of prognostic models: A population-based study. Can J Gastroenterol Hepatol (2015) 0.75

Colorectal cancer surveillance in patients with inflammatory bowel disease and primary sclerosing cholangitis: an economic evaluation. Inflamm Bowel Dis (2014) 0.75

Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease. Inflamm Bowel Dis (2017) 0.75

The Global Incidence of Appendicitis: A Systematic Review of Population-based Studies. Ann Surg (2017) 0.75

Corrigendum: Rural and Urban Residence During Early Life Is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study. Am J Gastroenterol (2017) 0.75

Global Birth Prevalence of Spina Bifida by Folic Acid Fortification Status: A Systematic Review and Meta-Analysis. Am J Public Health (2016) 0.75

Clinical Predictors of the Risk of Early Colectomy in Ulcerative Colitis: A Population-based Study. Inflamm Bowel Dis (2017) 0.75

Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel. Inflamm Bowel Dis (2016) 0.75

A Simple Ultrasound Score for the Accurate Detection of Inflammatory Activity in Crohn's Disease. Inflamm Bowel Dis (2017) 0.75

Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis. Inflamm Bowel Dis (2017) 0.75

Long-term Maintenance of Clinical, Endoscopic, and Radiographic Response to Ustekinumab in Moderate-to-Severe Crohn's Disease: Real-world Experience from a Multicenter Cohort Study. Inflamm Bowel Dis (2017) 0.75